Skip to content

Clinical trials

Recruiting Kidney Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Status: Recruiting Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20161
20211
20222
20231
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Changhai Hospital1
Children's Hospital of Fudan University1
Chinese PLA General Hospital1
Dimerix Bioscience Pty Ltd1
Eli Lilly and Company1
George (Beijing) Clinical Research Co. Ltd.1
Jinling Hospital, China1
Nanjing First Hospital, Nanjing Medical University1
Novartis Pharmaceuticals1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases12
Glomerulonephritis, IGA3
Renal Insufficiency, Chronic3
Glomerulonephritis2
Glomerulonephritis, Membranous2
Glomerulosclerosis, Focal Segmental2
Neoplasms2
Urologic Diseases2
Carcinoma1
Carcinoma, Renal Cell1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.